BlockNCT06265402
Retrolaminar Block Versus Tab Block in Abdomioasty
A study testing Tab block versus retrolaminar block in abdominal plastic surgery in people with Block, run by Tanta University at 1 site in Egypt.
Trial summary
The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Block
- What is being tested?
- Tab block versus retrolaminar block in abdominal plastic surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Jan 2024to 15 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 90patients aged 18/65years of both sexes and asa physical status one two and three undergoing abdominal plastic surgery
Who cannot join
- patient refusal Patient taking analgesia of chronic illness or have history of substance abuse Patient who are unable to describe their post operative pain Patient with history of coagulabathy Un cooperative patient Patient with known allergy to study drug Patient with infection at site needle puncture Patient with decompensated hepatic renal respiratory or cardiac disorder
Trial locations and contacts
1 site in 1 country.
Tayseer Abdelrahman contact
About this study
Official title: Comparison Between US Guided Retrolaminar Block and Transversus Abdominis Plane Block for Post Operative Analgesia in Patient Undergoing Abdominal Plastic Surgery
The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery
Read the detailed description
Pain from intra abdominal surgery is a combination of somatic and visceral pain visceral pain transmitted by autonomic nervous system via sympathetic fibers from plexuses in close proximity to the viscera them selves Regional anesthetic are commonly used to prevent or minimize these side effect the use of ultra sound nerve block are commonly use as apart of multimodal post operative analgesia The tab block is used to decrease the need of post operative analgesia in patient undergoing abdominal plastic surgery It was found an alternative approach to para vertebral block the retro laminar block is performed with us guided imaging to reduce pain post operative and need analgesia
- Conditions
- Block
- Being tested
- Tab block versus retrolaminar block in abdominal plastic surgery
- Medical subject headings
- Bites and Stings
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Tab block versus retrolaminar block in abdominal plastic surgeryProcedure or surgery
i inject 20ml bupivacine either 4mg dead in each side
| Study group | Role | What they receive |
|---|---|---|
| Retrolaminar block in abdominal plastic surgery | Active comparator | In first group induction done with general anaesthia then Patient will receive bilateral us guided rertrolaminar block then bubivacane ,25%with dexa methasone 4mg as addiditive injected on the lamina at dose 20ml injected each side Receives: Procedure: Tab block versus retrolaminar block in abdominal plastic surgery |
| Tab block as post operative analgesia in abdominal plastic surgery | Active comparator | In secound group after general anaesthia induction bilateral us guided tap block with ,25%bupivacaine with dexamethasone 4mg as addiditve injected on the lamina at doses 20ml in each side Receives: Procedure: Tab block versus retrolaminar block in abdominal plastic surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total dose of morphine consumption in the first postoperative 24hours
Total dose of morphine consumption in the first postoperative 24hours
Measured: First 24hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2024
- Study start15 Jan 2024
- Primary completion15 Oct 2025 (estimated)
- Study completion15 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BlockStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hadeel Elsagheer, Tanta University
- Investigators
- Hadeel Elsagheer, Principal investigator, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06265402
- Sponsor's protocol ID
- 36264
- Status last verified
- Feb 2024
- First submitted
- 11 Feb 2024
- Last updated
- 20 Feb 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison Between US Guided Retrolaminar Block and Transversus Abdominis Plane Block for Post Operative Analgesia in Patient Undergoing Abdominal Plastic Surgery
- ClinicalTrials.gov ID
- NCT06265402
- Acronym / sponsor ID
- 36264
- Conditions
- Block
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 15 Jan 2024 (actual)
- Primary completion
- 15 Oct 2025 (estimated)
- Study completion
- 15 Dec 2025 (estimated)
- First posted
- 20 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery
Detailed description
Pain from intra abdominal surgery is a combination of somatic and visceral pain visceral pain transmitted by autonomic nervous system via sympathetic fibers from plexuses in close proximity to the viscera them selves Regional anesthetic are commonly used to prevent or minimize these side effect the use of ultra sound nerve block are commonly use as apart of multimodal post operative analgesia The tab block is used to decrease the need of post operative analgesia in patient undergoing abdominal plastic surgery It was found an alternative approach to para vertebral block the retro laminar block is performed with us guided imaging to reduce pain post operative and need analgesia
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Retrolaminar block in abdominal plastic surgery | Active comparator | Procedure: Tab block versus retrolaminar block in abdominal plastic surgeryIn first group induction done with general anaesthia then Patient will receive bilateral us guided rertrolaminar block then bubivacane ,25%with dexa methasone 4mg as addiditive injected on the lamina at dose 20ml injected each side |
| Tab block as post operative analgesia in abdominal plastic surgery | Active comparator | Procedure: Tab block versus retrolaminar block in abdominal plastic surgeryIn secound group after general anaesthia induction bilateral us guided tap block with ,25%bupivacaine with dexamethasone 4mg as addiditve injected on the lamina at doses 20ml in each side |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 90patients aged 18/65years of both sexes and asa physical status one two and three undergoing abdominal plastic surgery
Key exclusion criteria (1 listed)
- patient refusal Patient taking analgesia of chronic illness or have history of substance abuse Patient who are unable to describe their post operative pain Patient with history of coagulabathy Un cooperative patient Patient with known allergy to study drug Patient with infection at site needle puncture Patient with decompensated hepatic renal respiratory or cardiac disorder
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Tab block versus retrolaminar block in abdominal plastic surgeryi inject 20ml bupivacine either 4mg dead in each side | Procedure or surgery | Retrolaminar block in abdominal plastic surgery, Tab block as post operative analgesia in abdominal plastic surgery |
Primary outcome
Total dose of morphine consumption in the first postoperative 24hours
Time frame: First 24hours
Total dose of morphine consumption in the first postoperative 24hours
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2024.
- Individual participant dataSharing planned: No
Related trials for Block
Recruiting
Comparison of Spinal Anesthesia With Intrathecal Morphine Versus PENG Block With or Without Dexamethasone in Hip Arthroplasty
Arthropathy of Hip, Hip Osteoarthritis
Active, not recruiting
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial
Aortic Valve Stenosis, Regurgitation, Aortic
Not yet recruiting
Magnesium Sulphate as an Adjuvant in Combined Costoclavicular Block and Suprascapular Block Versus Interscalene Block for Ambulatory Shoulder Arthroscopy
Postoperative Pain, Shoulder Arthroscopy
Recruiting
Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Osteoarthritis, Hip, Hip Osteoarthritis
Recruiting
A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke
Ischemic Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tayseer Abdelrahman contact
Hadeel Elsagheer principal investigator
Tanta University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Tab block versus retrolaminar block in abdominal plastic surgery in people with Block, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hadeel Elsagheer, Master (01090884208, Dodoelsagheer@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total dose of morphine consumption in the first postoperative 24hours (time frame: First 24hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.